Biodesix, Inc.BDSXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank71
3Y CAGR-2.9%
5Y CAGR+2.1%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-2.9%/yr
vs +12.5%/yr prior
5Y CAGR
+2.1%/yr
Recent deceleration
Acceleration
-15.4pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$12.00M+25.5%
2024$9.56M-4.3%
2023$9.99M-23.8%
2022$13.10M+2.4%
2021$12.79M+18.2%
2020$10.82M+3.3%
2019$10.47M+27.8%
2018$8.19M-